Delivery Order SPE2DB22D2007-SPE2DB25FJ3PW
- Not listed
- The Defense Logistics Agency awarded a $7,300.30 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Albumin (Human) 25% Intravenous Solution in 50mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,080.40 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Albumin (Human) 25% Intravenous Solution, 50mL. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,255.80 to AmerisourceBergen Drug Corp for the supply of Albumin (Human) 5% Intravenous Solution in 250ml units. This is a firm fixed-price delivery order with an ultimate completion date of October 8, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ml on June 16, 2025, with a ceiling value of $2,296.00 and ultimate completion date of July 9, 2025. This competitively awarded, firm fixed price delivery order was issued without a set-aside designation and will be performed in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Albumin (Human) 5% intravenous solution in 250ml units, with a ceiling value of $2,296. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Albumin (Human) 25% Intravenous Solution 50ml, with a ceiling value of $2,816.10 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,744.72 on August 21, 2025, for the supply of Albumin (Human) 25% intravenous solution in 50mL units. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Albumin (Human) 5% IV Solution in 250ml units, with a ceiling value of $1,506.96. This firm fixed-price delivery order is scheduled for completion by September 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency Medical Supply Chain on August 19, 2025, for the supply of Albumin (Human) 25% intravenous solution in 100-milliliter units. The contract is structured as a firm fixed price delivery order with a ceiling value of $9,984.96 and an ultimate completion date of September 10, 2025. This award was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate...
- This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3PWDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,296 delivery order to AmerisourceBergen Drug Corp for Human Albumin 5% intravenous solution in 250ml units. This firm fixed-price contract, awarded on August 4, 2025, with a completion date of August 25, 2025, carries no set-aside designation and represents a competitively awarded transaction. Performance will be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its DLA prime contract vehicle, which enables supply of pharmaceutical products and medical commodities to military healthcare systems and other government agencies worldwide. The company's contract portfolio demonstrates extensive federal procurement experience across therapeutic domains including specialty medications, vaccines, and medical supplies. This albumin delivery order represents a routine transaction within AmerisourceBergen's broader pharmaceutical supply mission supporting Defense Health Agency requirements and other military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/4/25 |